Euromonitor International, May 2010, Pages: 25
Thanks to an aggressive restructuring of its operations, American Express has emerged from a tumultuous year for the banking industry in relatively good shape. A renewed focus on premium charge
Frost & Sullivan, May 2010, Pages: 61
-generation sequencing technologies is significantly boosting new gene expression-related studies in Europe. The DNA microarrays market is in the late growth stage with a stable growth expected in the next five
GBI Research, April 2011, Pages: 72
decisions from the insightful and in-depth analysis of the global pipeline industry and the factorsshaping it “Pipeline Industry to 2015 - Energy Demand in Asia Pacific and Uptake of Unconventional Gas
Business Insights, Sep 2007, Pages: 182
drivers shaping the future of biomanufacturing.
Some key findings from this report...
-The biotechnology industry is now consistently delivering clinically successful drugs for the treatment of human
VRL Financial News Publishing, Oct 2008
India is the next big market for retail financial services.
This report uses exclusive interviews plus a survey of third party data to present the critical success factors in creating an Indian
Beachhead Consulting, Sep 2006
The expectation that microarray technology will play a large role in shaping the future of pharmaceutical development and diagnostics has greatly increased due to new products and applications
Business Insights, Jan 2006, Pages: 163
window into the perspectives and experiences of those leaders at the forefront of shaping that future.
This report includes expert findings from
- David Wood, CEO, Interbrand Wood Healthcare
- Max
Global Industry Analysts, Inc., Jan 2011, Pages: 408
Global Architectural Coatings Market - Snapshots 6
Global Wallpaper Market - Snapshots 6
3. CURRENT AND FUTURE ANALYSIS
Datamonitor, Oct 2011, Pages: 118
contribute to Brazil being a strategic market for new investments on the beauty segment?
- What are the key demographics that are shaping Brazilian females' consumption now and in the near future?
- What
Datamonitor, Sep 2011
:
- Use these insights into the behaviour of Australian credit card cutsomers across four product lifecycles to shape your acquisition strategy.
- Identify new opportunities by uncovering different consumer
Datamonitor, March 2011, Pages: 106
market share as a result of the focus on direct distribution, and uncertainty over the shape of proposed regulation of mortgage distribution.
Scope of the report:
- Presents findings from the Intermediary
Datamonitor, Sep 2010, Pages: 225
organic market in the US will grow at a slower rate than in Brazil and Canada in the next five years, albeit at a rate that will outpace the alcohol industry overall
Figure 41: The comparatively small
Datamonitor, June 2009, Pages: 109
consumers attach importance to individuality and being able to express themselves. This is symptomatic of changing value sets whereby cultures once regarded as being collectivist are increasingly shaped
Datamonitor, March 2010, Pages: 178
Skincare consumers deem value-for-money to be the main consideration when purchasing category products, but many factors impact choice. Brand is generally not as important to oral hygiene consumers
Business Insights, June 2002
and drink
industry professionals five years ago and in five years time 101
Figure 6.26: Industry respondent’s experience 102
Figure 7.27: Which factors will drive growth in the convenience market over
Datamonitor, Dec 2009, Pages: 132
such as self-expression and post-materialism
- Global coverage: includes data from two waves of proprietary consumer insight research covering 17 countries across five continents
- Detailed recommendations
Datamonitor, April 2010, Pages: 185
, but accepting personal responsibility to address them. In turn, industry players have acknowledged that environmentalism is now a key battleground in the fight to win the hearts and minds of consumers.
Scope
Espicom Business Intelligence Ltd, June 2009, Pages: 472
of the pharmaceutical industry’s future and critical to bringing novel therapies to market.
Indeed, without the ability to effectively deliver targeted drugs in therapeutically significant quantities, many of the gene